At the Special Clinic, I see patients with cutaneous adverse drug reactions from the University Hospital and referred cases that are difficult to diagnose and treat. For severe cases, follow-up care after the severe symptoms abate is particularly important. Final identification of the causative drugs and long-term monitoring of DIHS are done at the clinic.

In fiscal 2013, I treated one case of toxic epidermal necrolysis (TEN), five cases of Stevens-Johnson syndrome (SJS) and five cases of DIHS (including a suspected case). The accumulation of data on severe cases of cutaneous adverse drug reactions has progressed, and I was able to publish papers in which I used that information (e.g., J Allergy Clin Immunol 2013, Clin Immunol 2013). I’m grateful to the referring doctors. If you have any drug eruption cases—or suspected cases—that are hard to diagnose or treat, please feel free to refer them to the clinic.